Longitudinal “Real-World” Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece
BackgroundPirfenidone is an antifibrotic compound able to slow down disease progression in patients with idiopathic pulmonary fibrosis (IPF).ObjectiveTo investigate the safety and efficacy of pirfenidone in patients with IPF in a real-life setting.MethodsThis was a multicenter, retrospective, real-l...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2017-11-01
|
| Collection: | Frontiers in Medicine |
| Sujets: | |
| Accès en ligne: | http://journal.frontiersin.org/article/10.3389/fmed.2017.00213/full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|